There is no question that one of the top nonprescription categories contributing to both sales and foot traffic right now is allergy. Sales of nasal sprays — the category that captures all of the latest nasal corticosteroid Rx-to-OTC switches — are up 10.2%.
Sales of all OTC medicines and natural supplements broke records in 2016, reaching $45.8 billion for the 52 weeks ended Dec. 25, 2016, according to IRI. That’s an additional $1.8 billion in sales volume compared with a year ago.
DSN senior editor Michael Johnsen examines the hottest trends in OTC — including breakthrough brands and such growth categories as therables, sleep, allergy, cough-cold and more — in this multi-page report.
The UR nasal subcategory saw impressive growth in the channels studied, due in large part to the recent Rx-to-OTC switch products in the nasal corticosteroid segment, driving sales up 15% in the food industry and up to10% in drug.
Xyzal is an antihistamine containing the active ingredient levocetirizine dihydrochloride and provides 24-hour relief from runny nose, sneezing, itchy watery eyes and itching of the nose or throat in a single daily dose.
RB is in search of Indiegogo campaigners whose innovations specifically fit within the following focus categories: respiratory, pain relief, health monitoring, sexual well-being and vitamins, minerals and supplements.